Home LiteratureArticle Details
PMID: 9185519 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

The Journal of clinical investigation ·Vol. 99 ·No. 12 ·1997-06-15 ·Pages 2950-60

Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, Meguid El Nahas A

Abstract

Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of epsilon-(gamma-glutamyl) lysine bonds. This crosslinking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of epsilon-(gamma-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47+/- 0.94 (mean+/-SEM) in controls to 13.24+/-1.43 nmol/g protein 90 d after SNx, P </= 0.01. Levels of epsilon-(gamma-glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P </= 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77+/-0.35 to 13.93+/-4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in epsilon-(gamma-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the epsilon-(gamma-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product, epsilon-(gamma-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, epsilon-(gamma-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.

MeSH Terms
Animals Cross-Linking Reagents Cytoplasm/chemistry DNA/metabolism Dipeptides/analysis,metabolism Disease Models, Animal Extracellular Matrix Proteins/metabolism Extracellular Space/chemistry Fibrosis Fluorescent Antibody Technique Immunohistochemistry Kidney/pathology Kidney Glomerulus/pathology Kidney Tubules/pathology Male Nephrectomy Rats Rats, Wistar Transglutaminases/metabolism
Chemicals
Cross-Linking Reagents Dipeptides Extracellular Matrix Proteins epsilon-(gamma-glutamyl)-lysine DNA Transglutaminases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Johnson T S
Sheffield Kidney Institute, Northern General Hospital NHS Trust, Sheffield S5 7AU, United Kingdom. [email protected]
Griffin M
Thomas G L
Skill J
Cox A
Yang B
Nicholas B
Birckbichler P J
Muchaneta-Kubara C
Meguid El Nahas A
References (51)
51 references, click to expand
  1. Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes.
    J Biol Chem. 1990 Jul 5;265(19):11098-104 PMID: 1972706
  2. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen.
    J Biol Chem. 1987 Jan 25;262(3):1022-4 PMID: 2879837
  3. Retinoids induce tissue transglutaminase in NIH-3T3 cells.
    Biochem Biophys Res Commun. 1991 Mar 29;175(3):1119-24 PMID: 1673838
  4. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  5. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy.
    Kidney Int. 1992 Sep;42(3):573-85 PMID: 1383596
  6. Matrix metalloproteinases: a review.
    Crit Rev Oral Biol Med. 1993;4(2):197-250 PMID: 8435466
  7. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.
    Proc Natl Acad Sci U S A. 1982 Oct;79(19):6070-4 PMID: 6136967
  8. The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of alpha 2IV collagen mRNA expression by competitive polymerase chain reaction.
    J Exp Med. 1992 Dec 1;176(6):1571-6 PMID: 1281210
  9. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action.
    FEBS Lett. 1989 Mar 13;245(1-2):150-4 PMID: 2564346
  10. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.
    J Biol Chem. 1991 Aug 15;266(23):15308-17 PMID: 1678389
  11. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein.
    Cell. 1977 Jun;11(2):417-22 PMID: 890737
  12. Transglutaminases.
    Annu Rev Biochem. 1980;49:517-31 PMID: 6105840
  13. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme.
    J Cell Physiol. 1991 Dec;149(3):375-82 PMID: 1683874
  14. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.
    Oncogene. 1994 Oct;9(10):2935-42 PMID: 7916148
  15. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
    Biochim Biophys Acta. 1991 Jun 5;1096(4):312-8 PMID: 1676603
  16. The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization.
    Blood. 1987 Sep;70(3):702-9 PMID: 2887223
  17. Transglutaminase activity and N epsilon (gamma glutamyl) lysine isopeptide levels during cell growth: an enzymic and immunological study.
    Int J Cancer. 1991 May 10;48(2):221-6 PMID: 1673452
  18. Lipoprotein binding of crosslinked type III collagen aminopropeptide and fractions of its antigen in blood.
    Biochem Biophys Res Commun. 1990 Jul 31;170(2):519-25 PMID: 1974421
  19. Detection of epsilon(gamma-glutamyl) lysine.
    Mol Cell Biochem. 1984;58(1-2):37-49 PMID: 6143252
  20. Effect of putrescine on tissue transglutaminase activity in wounds: decreased breaking strength and increased matrix fucoprotein solubility.
    Plast Reconstr Surg. 1994 Mar;93(3):567-73 PMID: 7906892
  21. The red cell membrane contains calmodulin-regulated crosslinking and proteolytic activity.
    Hematol Pathol. 1991;5(4):185-93 PMID: 1686607
  22. Role of growth hormone in the development of experimental renal scarring.
    Kidney Int. 1991 Jul;40(1):29-34 PMID: 1921152
  23. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
    J Neurochem. 1993 Sep;61(3):1159-62 PMID: 8103081
  24. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
    J Cell Biol. 1993 Apr;121(2):439-48 PMID: 8096847
  25. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate.
    J Cell Biol. 1995 May;129(3):881-92 PMID: 7730416
  26. Apoptosis: molecular mechanisms in programmed cell death.
    Eur J Cell Biol. 1991 Dec;56(2):170-7 PMID: 1802705
  27. Role of ICE-related and other proteases in Fas-mediated apoptosis.
    Cell Death Differ. 1996 Apr;3(2):177-84 PMID: 17180080
  28. Correlation between endogenous creatinine clearance and relative interstitial volume of the renal cortex in patients with diffuse membranous glomerulonephritis having a normal serum creatinine concentration.
    Lab Invest. 1980 Aug;43(2):145-9 PMID: 7401629
  29. The existence of an inactive form of transglutaminase within metastasising tumours.
    Biochim Biophys Acta. 1990 Jun 12;1053(1):13-20 PMID: 1973055
  30. Induction and activation of tissue transglutaminase during programmed cell death.
    FEBS Lett. 1987 Nov 16;224(1):104-8 PMID: 2890537
  31. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes.
    J Immunol. 1994 Jul 15;153(2):507-16 PMID: 8021492
  32. The fibronectin-binding domain of transglutaminase.
    J Biol Chem. 1995 Mar 10;270(10):5654-8 PMID: 7890687
  33. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury.
    Am J Physiol. 1996 Mar;270(3 Pt 2):F500-9 PMID: 8780254
  34. Interactions of factor XIII with fibrin as substrate and cofactor.
    Biochemistry. 1992 Jan 21;31(2):423-9 PMID: 1731900
  35. Transglutaminases.
    Mol Cell Biochem. 1984;58(1-2):9-35 PMID: 6143256
  36. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells.
    Biochemistry. 1995 Oct 24;34(42):13768-75 PMID: 7577969
  37. Inhibition of beta-crystallin cross-linking in the Ca2+-treated lens.
    Invest Ophthalmol Vis Sci. 1987 Jul;28(7):1218-22 PMID: 3596999
  38. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis.
    Eur J Cell Biol. 1993 Feb;60(1):210-6 PMID: 8096461
  39. A monoclonal antibody to cellular transglutaminase.
    Hybridoma. 1985 Summer;4(2):179-86 PMID: 2861155
  40. Apoptosis in glomerular sclerosis.
    Kidney Int. 1996 Jan;49(1):103-11 PMID: 8770955
  41. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat.
    Br J Exp Pathol. 1979 Dec;60(6):653-61 PMID: 44202
  42. Transglutaminase-catalysed cross-linking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen.
    Thromb Res. 1989 May 15;54(4):357-67 PMID: 2569775
  43. Polyamines and uremia.
    Adv Exp Med Biol. 1987;223:47-54 PMID: 3447450
  44. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria.
    Kidney Int. 1995 Jun;47(6):1546-57 PMID: 7643523
  45. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.
    FASEB J. 1991 Dec;5(15):3071-7 PMID: 1683845
  46. Increase in epsilon(gamma-glutamyl)lysine crosslinks in atherosclerotic aortas.
    Atherosclerosis. 1994 Dec;111(2):247-53 PMID: 7718027
  47. Increased transglutaminase activity during skin wound healing in rats.
    Biochim Biophys Acta. 1988 Nov 17;967(2):234-40 PMID: 2903771
  48. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.
    Adv Protein Chem. 1977;31:1-133 PMID: 73346
  49. Cytokines in kidney disease: the role of transforming growth factor-beta.
    Am J Kidney Dis. 1993 Jul;22(1):105-13 PMID: 8322771
  50. Morphometric correlates of renal excretory function.
    J Pathol. 1990 Mar;160(3):245-53 PMID: 2335805
  51. Localization of transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney.
    Kidney Int. 1995 Mar;47(3):733-9 PMID: 7752571
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1997-06-15
Pages
2950-60
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508147
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]